Breast cancer medical oncologist, translational researcher and clinical trialist with focus on immunotherapy and the tumor microenvironment
UT Southwestern Medical Center
Joined August 2017
- Tweets370
- Following148
- Followers782
- Likes844
Grateful to have been part of this important work on dual immune checkpoint blockade in metastatic breast cancers! Congrats to all the authors!
The #NIMBUS trial results are now published in @NatureComms 👉Nivolumab plus low-dose #ipilimumab in hypermutated HER2-negative #MetastaticBreastCancer.
🔓pubmed.ncbi.nlm.nih.gov/4036…
✍️@jgtzanudo @smreddymd @EmensLeisha @CarolinaAlvesC5 @s_aldubayan @hoyin_chu @nlinmd
@NabihahTayob @RMJesel @EMittendorfMD
@stolaney1
Sangeetha Reddy retweeted
#AACR25, capturing the last night at AACR grantee award reception along with @utswcancer colleague @smreddymd ! Managed to take a photo with the one and only @AACR_CEO !Thanks the grant support from @AACR @kidneycan
Sangeetha Reddy retweeted
Big congratulations @smreddymd @utswcancer !!
We congratulate Sangeetha Reddy, MD, recipient of a 2024 Victoria’s Secret Global Fund for Women’s Cancers Career Development Award, in Partnership with Pelotonia & AACR. Dr. Reddy will study the impact of CD40 agonists on the myeloid CD8 T cell axis.
@VictoriasSecret @Pelotonia
Sangeetha Reddy retweeted
@UTSWInternalMed #GrandRounds with @smreddymd highlighting immunotherapy for breast cancer and her translational efforts. Our breast cancer team is strong @utswcancer @UTSWHemeOnc! @CarlosArteagaMD @suzanneconzenmd @hmcarthur
Big congrats!!!
Read it here: cell.com/cell-reports-medici… Happy to talk more- How can we use our lab's tools & data to help you?
Led by Lily Xu @UTSWMedCenter Med student, Katilyn Saunders, and Shawn Huang @UTSWmstp. 🙏 to funders @SusanGKomen @metavivor @theNCI. Collab w/ @GRASPtweets who gave *great* patient insight & Lin Xu, @smreddymd @hmcarthur @utswcancer, & my dear friend who knows @tomhanks @RoussosTorres. @UTSWHemeOnc @BiotechClubUTSW @UTSWInternalMed @UTSWCancerBio @CellRepMed
Excited to share our updated pre-clinical data on combination CD40 agonist + Flt3L + Doxil in breast cancer with @PreteeshLeo. @utswcancer #aacr24
Sangeetha Reddy retweeted
#SABCS23 | Poster PO2-27-12 | Genomic determinants of benefit to nivolumab + low dose ipilimumab among patients with hypermutated HER2- #MBC: Results of #NIMBUS trial. #MetastaticBreastCancer @DrRBarroso @stolaney1 @nlinmd @nabihahtayob @emittendorfmd @RMJesel @smreddymd
Sangeetha Reddy retweeted
After my wonderful experience at @MDAndersonNews, I've realized there is a robust academic life beyond it. Certainly, those who remain at or return to MDA also enjoy fulfilling careers. I've learned that various cancer centers contribute uniquely to breast cancer research. #SABCS23 – at San Antonio, TX
Sangeetha Reddy retweeted
Tumor Agnostic Approaches to Care: @VivekSubbiah, Joshua Z. Drago, @DrMiaLevy, and Marleen Kok addressed this topic in a Clinical Workshop moderated by Sangeetha M. Reddy this afternoon at #SABCS23.
@lab_kok @smreddymd @AACR @UTHealthSAMDA @OncoAlert
Looking forward to moderating this session and hearing some stellar talks in Stars at Night Ballroom in just a few minutes! @SABCSSanAntonio @utswcancer #sabcs23
Join us for tumor-agnostic session @SABCSSanAntonio #SABCS23. What can we as BC physicians and investigators learn from other tumor types and how best to collaborate! With stellar speakers @VivekSubbiah
Sangeetha Reddy retweeted
The cancer #immunity cycle provides a framework to understand the series of events that generate anti-cancer immune responses. Check out this revised review that helps better understand the successes & failures of cancer #immunotherapy doi.org/10.1016/j.immuni.202…
Sangeetha Reddy retweeted
It is not uncommon for clinician scientists to be questioned whether they’re ‘real doctors’ or ‘true scientists’
Both
The secret to a long life as a clinician scientist is the same as a long marriage. Selective deafness
Great paper @ESMO_Open @DrJonLim
esmoopen.com/article/S2059-7…
Sangeetha Reddy retweeted
Highlighting the important role the innate immune system plays in immunotherapy, @smreddymd delivers an excellent lecture describing the rationale for augmenting CDK4/6i and ICB with dendritic cell therapy. #DAVAHawaiiBreast jitc.bmj.com/content/11/5/e0…
Starting Now: Immunotherapy in Breast Cancer - (Vaccine Strategies). Moderated by: Vered Stearns #DAVAHawaiiBreast
Excited to share our work with @avilgelm showing dendritic cell therapy augments anti-tumor immunity with CDK4/6i and immune checkpoint blockade!
jitc.bmj.com/content/11/5/e0…
We did it! 7 mo of training, 9 days of hiking in the mountains, the hardest thing by far I’ve done to peak Mt Kilimanjaro…soaring above the clouds & making new family along the way…learned anything can be done by going pole pole (slow) one step at a time! An amazing experience!
We have a post-doc position @utsw available! Please RT and DM me if interested in a position in translational breast tumor immunology and immunotherapy. We're doing very exciting work focused on enhancing antigen presentation. labs.utsouthwestern.edu/redd… #postdocjobs
Sangeetha Reddy retweeted
Incredible presentation at #SABCS2022 on InteractPrint by Student Doctor Lily Xu from @ithinkichan Lab! Stellar mentorship by Dr. Chan to feature this rising star at a general session! Grateful for this incredible collaboration @smreddymd @utswcancer and excited for more to come!
Sangeetha Reddy retweeted
PD1-blockade back in the game for ER+ breast cancer! 🎊Congrats to PACE trialists. 👏👏Impressive OS for pts treated with avelumab, most important no special tox in contrast to Cm7A8 and abema/pembro. aPD1 vs aPDL1? #sabcs22. #bcsm @SABCSSanAntonio
